BookJ. Rick Turner, Dilip R. Karnad, Snehal Kothari.
Contents:
The Central Importance of Cardiovascular Safety in Contemporary New Drug Development
The Biological Basis of Drug Responses
Cardiovascular Structure, Function, Pathophysiology, & Disease
The Current Regulatory Landscape
The "Comprehensive In Vitro Proarrhythmia Assay" Initiative
The "Early ECG Assessment" Initiative
The "Submission of Extended Digital ECG Data" Initiative
Meta-analysis and Meta-methodology
Current Regulatory Landscapes and their Potential Evolution
Off-target Blood Pressure Responses to Non-cardiovascular Drugs
Oncology Drug Development and Therapeutics: Cardiotoxicity Considerations
Postmarketing Surveillance
Regulatory Perspectives on General Drug Safety
Future Directions in Cardiovascular Safety
References.